Research programme: Antibody therapeutics - Epsilon Molecular Engineering/Ono Pharmaceutical
Latest Information Update: 22 Mar 2024
At a glance
- Originator Epsilon Molecular Engineering; Ono Pharmaceutical
- Class Antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified